EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
Clinical trial NCT01192464 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01192464
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-10
- Primary completion
- 2012-05-29
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.